Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system
Braz. J. Pharm. Sci. (Online); 53 (3), 2017
ABSTRACT Human insulin is provided by the Brazilian Public Health System (BPHS) for the treatment of diabetes, however, legal proceedings to acquire insulin analogs have burdened the BPHS health system. The aim of this study was to perform a cost-effectiveness analysis to compare insulin analogs and huma...
Insulinas/análisis, Análisis Costo-Beneficio/22074, Hemoglobina Glucada, Insulina de Acción Prolongada/análisis, Insulina de Acción Corta/análisis, Diabetes Mellitus/tratamiento farmacológico, Sistema Único de Salud/estadística & datos numéricos, Insulina/provisión & distribución, Costos y Análisis de Costo, Insulina Aspart/análisis, Insulina Detemir